ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.

Katherine A Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.